ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

RETaliation-Tackling Rare Resistance Alterations to Osimertinib.

Matthew G Krebs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.